Uncertainty and coping in patients with newly diagnosed indolent non-Hodgkin's lymphoma (iNHL)

被引:0
|
作者
Newcomb, Richard
Johnson, Patrick Connor
Yang, Daniel
Amonoo, Hermioni L.
Dhawale, Tejaswini More
Chen, Yi-Bin Albert
El-Jawahri, Areej
机构
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7568
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Current therapeutic approaches to patients with newly diagnosed low-grade non-Hodgkin's lymphoma
    Gregory, Stephanie A.
    SEMINARS IN HEMATOLOGY, 2007, 44 (03) : S7 - S11
  • [42] Being diagnosed with cancer: The experiences of patients with non-Hodgkin's lymphoma
    Chircop, Daren
    Scerri, Josianne
    JOURNAL OF CLINICAL NURSING, 2017, 26 (23-24) : 4899 - 4904
  • [43] Primary lymphoma of the conjunctiva - A rare manifestation of indolent non-Hodgkin's lymphoma
    Reiser M.
    Josting A.
    Diehl V.
    Engert A.
    Annals of Hematology, 2001, 80 (5) : 311 - 313
  • [44] Primary lymphoma of the conjunctiva - a rare manifestation of indolent non-Hodgkin's lymphoma
    Reiser, M
    Josting, A
    Diehl, V
    Engert, A
    ANNALS OF HEMATOLOGY, 2001, 80 (05) : 311 - 313
  • [45] Comparative effectiveness of treatments for newly diagnosed follicular non-Hodgkin lymphoma
    Messori, Andrea
    Fadda, Valeria
    Maratea, Dario
    Trippoli, Sabrina
    LEUKEMIA & LYMPHOMA, 2015, 56 (09) : 2728 - 2730
  • [46] ECONOMIC EVALUATION OF BENDAMUSTINE IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN'S LYMPHOMA IN MEXICO
    Salazar, A.
    Aguirre, A.
    Herrera, M.
    VALUE IN HEALTH, 2017, 20 (05) : A215 - A215
  • [47] Effectiveness and tolerability of radiotherapy for patients with indolent non-Hodgkin’s lymphoma: a monocenter analysis
    I. Hadi
    A. Schummer
    M. Dreyling
    C. Eze
    R. Bodensohn
    O. Roengvoraphoj
    C. Belka
    M. Li
    Scientific Reports, 11
  • [48] Introduction: Treatment of patients with rituximab-refractory indolent non-hodgkin's lymphoma
    Gregory, Stephanie A.
    SEMINARS IN HEMATOLOGY, 2007, 44 (03) : S1 - S1
  • [49] Population pharmacokinetics of bendamustine and metabolites in patients with indolent non-hodgkin's lymphoma (NHL).
    Owen, J. S.
    Melhem, M.
    D'Andrea, D.
    Darwish, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S54 - S55
  • [50] Effectiveness and tolerability of radiotherapy for patients with indolent non-Hodgkin's lymphoma: a monocenter analysis
    Hadi, I
    Schummer, A.
    Dreyling, M.
    Eze, C.
    Bodensohn, R.
    Roengvoraphoj, O.
    Belka, C.
    Li, M.
    SCIENTIFIC REPORTS, 2021, 11 (01)